Clinical Laserthermia Systems AB (publ)
SSE:CLS-B.ST
0.1015 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||||||
Net Income
| -79.792 | -70.689 | -63.615 | -57.939 | -43.375 | -32.855 | -21.264 | -26.949 | -16.595 | -17.841 | -18.325 | -12.697 | -6.975 | -4.954 | -1.977 | -0.671 |
Depreciation & Amortization
| 2.708 | 2.45 | 0.684 | 3.056 | 2.681 | 0.209 | 0.176 | 0.053 | 0.053 | 0.056 | 0.116 | 0.12 | 0.087 | 0.087 | 0.06 | 0.048 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | -3.356 | 7.429 | -2.116 | 2.107 | -0.225 | 0.531 | 0.923 | 0 | 0 | 0 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | -0.459 | 0.021 | 0.457 | -0.195 | -0.359 | -0.429 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | -3.238 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | -0.002 | 1.126 | -2.537 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | -0.118 | 6.283 | -0.035 | 0.186 | 0.134 | 0 | 0 | 0 | 0 | 0 |
Other Non Cash Items
| 16.045 | -2.45 | -3.244 | -0.524 | 1.572 | 32.646 | 0.058 | -0.161 | -0.02 | -0.065 | 18.209 | 0 | 0.005 | 4.867 | 1.917 | 0.624 |
Operating Cash Flow
| -66.455 | -70.689 | -66.175 | -55.407 | -39.122 | -38.724 | -24.386 | -19.627 | -18.677 | -15.743 | -18.303 | -12.046 | -5.96 | -4.918 | -2.278 | -0.069 |
Investing Activities: | ||||||||||||||||
Investments In Property Plant And Equipment
| -5.497 | -0.562 | -0.555 | -0.348 | 0 | -2.376 | -4.673 | -1.541 | -1.897 | -2.415 | -2.446 | -2.059 | -1.79 | -1.905 | -3.317 | -2.012 |
Acquisitions Net
| 0 | 0 | 0 | 0.16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | -0.324 | 0 | -0.198 | -0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0.147 | 0.038 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| -3.354 | -0.324 | -0.262 | -0.16 | -0.04 | -2.334 | -3.688 | -1.541 | -1.897 | -2.415 | -2.446 | -1.792 | 0 | 0 | 0 | 0 |
Investing Cash Flow
| -5.497 | -0.886 | -0.408 | -0.508 | -0.04 | -2.376 | -4.673 | -1.541 | -1.897 | -2.415 | -2.446 | -2.059 | -1.79 | -1.905 | -3.317 | -2.012 |
Financing Activities: | ||||||||||||||||
Debt Repayment
| -30.678 | -0.2 | -0.4 | -15.4 | -0.4 | -0.4 | -0.2 | 0 | 0 | 0 | -0.033 | -0.173 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 107.372 | 57.044 | 71.277 | 62.425 | 0.726 | 50.269 | 36.762 | 24.737 | 4.5 | 23.359 | 27.321 | 18.96 | 0 | 8.683 | 4.928 | 3.402 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 107.372 | 5 | 15 | 15 | 20 | 50.269 | 2 | 24.737 | 4.5 | 23.359 | 27.321 | 18.787 | 7.208 | -0.21 | -0.063 | 0.406 |
Financing Cash Flow
| 76.694 | 61.844 | 85.877 | 62.025 | 20.326 | 49.869 | 38.562 | 24.737 | 4.5 | 23.359 | 27.288 | 18.787 | 7.208 | 8.473 | 4.865 | 3.809 |
Other Information: | ||||||||||||||||
Effect Of Forex Changes On Cash
| 0.14 | -10.845 | 0 | 0 | 0.172 | 0.016 | -0.06 | 0 | 0 | 0 | -0.09 | 0.006 | -0.005 | 0 | 0 | -0.002 |
Net Change In Cash
| 4.882 | -20.576 | 19.294 | 6.11 | -18.664 | 8.785 | 9.442 | 3.569 | -16.074 | 5.201 | 6.449 | 4.688 | -0.546 | 1.65 | -0.73 | 1.725 |
Cash At End Of Period
| 15.331 | 10.589 | 31.165 | 11.871 | 5.761 | 24.425 | 15.64 | 6.198 | 2.629 | 18.704 | 13.502 | 7.053 | 2.366 | 2.912 | 1.262 | 1.992 |